GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
2018's Information
トップページ
Information
2018年
All
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2018/12/20
New policy applied for procurement of drug products in China
2018/12/10
GNI Group Ltd. Ranked 351st on Deloitte Technology Fast 500 Asia Pacific 2018, A Ranking Program of Fastest-Growing Technology Companies
2018/10/25
Cullgen files 2 patents and presents at the Targeted Protein Degradation Summit at Boston, USA
2018/10/22
GNI Group Ltd. Ranks 22nd in 2018 Deloitte Touche Tohmatsu LLC Japan Technology Fast50, A Ranking of Fastest-Growing Technology Companies
2018/09/07
Participation in 2018 MIC (Mizuho Investment Conference) Tokyo
2018/08/01
Comments on recent inquiries
2018/07/11
Executives of Cullgen Inc. (Cullgen) and GNI Group Ltd. (GNI Group) have been invited to present research findings at three international drug discovery conferences in US and China.
2018/07/05
Updated schedule for change of share unit and reverse share split
2018/07/04
The progress of construction of Beijing Continent’s new plant in Hebei province
2018/06/22
Dr. Ying Luo, President and CEO of GNI Group Ltd., was interviewed by Shanghai Pudong TV and Oriental Finance channels for his entrepreneurship
1
2
>